| 1. |
I
have reviewed this report on Form 10-Q of Ohr Pharmaceutical,
Inc; |
| |
|
|
| 2. |
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report; |
| |
|
|
| 3. |
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report; |
| |
|
|
| 4. |
The
registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) for the registrant and
have: |
| |
|
|
| |
a) |
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report
is being prepared; |
| |
|
|
| |
b) |
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles; |
| |
|
|
| |
c) |
Evaluated
the effectiveness of the registrant’s
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on
such evaluation; and |
| |
|
|
| |
d) |
Disclosed
in this report any change in the
registrant’s internal control over financial reporting that
occurred during the registrant’s most
recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal
control over financial reporting; and |
| |
|
|
| 5. |
The
registrant’s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the
audit committee of the registrant’s
board of directors (or persons performing the equivalent
functions): |
| |
|
|
| |
a) |
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the
registrant’s ability to record, process, summarize and report
financial information; and |
| |
|
|
| |
b) |
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the
registrant’s internal control over financial
reporting. |